Finance
Beta
search
Search or ask
settings
Theme
mobile
Device default
✓
dark_mode
Dark theme
light_mode
Light theme
Search labs
feedback
Send feedback
Sign in
Lists
playlist_add
New
ADTX
Research
ADTX:NASDAQ
check_indeterminate_small
Aditxt Inc
$0.015
arrow_downward
-19.46%
(
-0.0036
) 1D
Jun 11, 10:12:30 AM GMT-4 · USD
area_chart
Area
stacked_line_chart
Compare
search
close
All symbols
monitoring
Indicators
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
Symbol
Price
Change
% Change
Overview
Earnings
Financials
Holdings
insights_auto
Generating top insights for ADTX...
Open
$0.02
High
$0.02
Low
$0.01
Mkt. cap
11.54K
Avg. vol.
31.56M
Volume
387.91M
52-wk high
$53,450.60
52-wk low
$0.01
EPS
-$31,151.01
Beta
0.83
Shares outstanding
816.00K
No. of employees
26
Open
$0.02
High
$0.02
Low
$0.01
Mkt. cap
11.54K
Avg. vol.
31.56M
Volume
387.91M
52-wk high
$53,450.60
52-wk low
$0.01
EPS
-$31,151.01
Beta
0.83
Shares outstanding
816.00K
No. of employees
26
Related stocks
ZCMD
Zhongchao Inc
$0.73
-4.13%
arrow_downward
HUBC
Hub Cyber Security Ltd
$1.33
-8.21%
arrow_downward
WOK
Work Medical Technology Group Ltd
$0.095
-5.40%
arrow_downward
HKIT
Hitek Global Inc
$0.50
+14.66%
arrow_upward
News stories
From sources across the web
Benzinga
·
2 hours ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Stocktwits
·
5 hours ago
ADTX Stock Rockets 90% Premarket: What's Fueling Rebound After A Record 22-Day Selloff?
Pharmaceutical Business review -
·
6 hours ago
Medicine,Factory,Scientist,Worker,Work,In,Laboratory,Plants,Process.,Medical
Investing.com
·
11 hours ago
Aditxt 10% owners sell $6,880 in common stock
Show more
About Aditxt Inc
CEO
-
Employees
26
Founded
2017
Headquarters
Richmond, Virginia, United States
Sector
Biotechnology
Website
aditxt.com
Previous reports
All values in USD
Loading Previous Earnings...
Income statement
Balance sheet
Cash flow
Income statement
Revenue
Net income
calendar_month
Quarterly
Quarterly
Annual
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.00K
748.00
425.00
12.16K
Cost of goods sold
1.00K
732.00
456.00
9.29K
Cost of revenue
1.00K
732.00
456.00
9.29K
Research and development expenses
764.33K
672.04K
548.56K
1.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.39M
2.47M
4.12M
3.32M
Operating expense
6.15M
3.14M
4.67M
4.36M
Total operating expenses
6.15M
3.14M
4.67M
4.37M
Operating income
-6.15M
-3.14M
-4.67M
-4.36M
Other non operating income
-62.23K
2.51M
358.64K
-11.78M
EBT including unusual items
-7.40M
-24.21M
-5.23M
-16.19M
EBT excluding unusual items
-7.40M
-855.75K
-4.73M
-16.19M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.26M
-24.05M
-4.70M
-15.95M
Net profit margin
-722,789.64%
-3,214,626.34%
-1,106,277.41%
-131,159.84%
Earnings per share
-
-
-
-
Interest and investment income
78.57K
183.63K
-
280.00
Interest expense
-1.26M
-410.69K
-422.08K
-51.82K
Net interest expenses
-1.18M
-227.06K
-422.08K
-51.54K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.08M
-3.07M
-4.61M
-4.31M
Gain or loss from assets sale
-
-
-
-
Insiders
Politicians
Insider transactions
Insider transactions data is drawn from third-party sources.
Learn more
Insider
Position
Type
Date
Shares
Amount
first_page
keyboard_arrow_left
Page 1
keyboard_arrow_right
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer
Research
edit_square
New thread
notes_spark
Thread history
close
Collapse
expand_content
Expand
add
Add Tool
travel_explore
Deep Search
arrow_upward
Ask AI
search_spark
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer